Skip to main content
. 2022 Jan 13;14:205–214. doi: 10.2147/CMAR.S347242

Table 3.

Univariate and Multivariate Analyses of Overall Survival (After PSM)

Risk Factors Univariate Analysis Multivariate Analysis
HR (95% CI) P value HR (95% CI) P value
Age (>/≤69 years) 2.007 (1.486–2.710) 0.000* 1.843 (1.350–2.515) 0.000*
Sex (male/female) 0.891 (0.660–1.202) 0.449
BMI (>/≤23.4 kg/m2) 0.658 (0.484–0.895) 0.008* 0.706 (0.516–0.965) 0.029*
Hypertension (yes/no) 1.032 (0.767–1.390) 0.834
T2DM (yes/no) 0.956 (0.712–1.283) 0.764
Tumor site (colon/rectum) 1.193 (0.889–1.601) 0.240
Tumor stage (III/II/I) 1.556 (1.253–1.931) 0.000* 1.587 (1.273–1.979) 0.000*
Smoking (yes/no) 0.884 (0.646–1.208) 0.438
Drinking (yes/no) 0.775 (0.551–1.089) 0.142
Family history (yes/no) 0.863 (0.382–1.948) 0.723
CHD (yes/no) 1.086 (0.658–1.791) 0.747
Adjuvant therapy (yes/no) 0.799 (0.354–1.806) 0.590
Overall complications (yes/no) 1.898 (1.407–2.561) 0.000* 1.496 (1.077–2.077) 0.016*
Major complications (yes/no) 2.940 (1.635–5.287) 0.000* 2.767 (1.270–6.029) 0.010*
Anastomotic leakage (yes/no) 2.542 (1.298–4.979) 0.007* 1.225 (0.513–2.929) 0.648

Note: *P-value <0.05.

Abbreviations: HR, hazard ratio; CI, confidence interval; BMI, body mass index; T2DM, type 2 diabetes mellitus; CHD, coronary heart disease; PSM, propensity score matching.